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Abstract 
Acinetobacter baumannii, one of the more clinically relevant species in the Acinetobacter genus 
is well known to be multi-drug resistant and associated with bacteremia, urinary tract infection, 
pneumonia, wound infection and meningitis. However, it cannot be differentiated from closely 
related species such as A. calcoaceticus, A. pittii and A. nosocomialis by most phenotypic tests 
and can only be differentiated by specific, time consuming genotypic tests with very limited use 
in clinical microbiological laboratories. As a result, these species are grouped into the A. 
calcoaceticus – A. baumannii (Acb) complex. Herein we investigated the mass spectra of 73 
Acinetobacter spp., representing ten different species, using an AB SCIEX 5800 MALDI – TOF 
MS to differentiate members of the Acinetobacter genus, including the species of the Acb 
complex. RpoB gene sequencing, 16S rRNA sequencing, and gyrB multiplex PCR were also 
evaluated as orthogonal methods to identify the organisms used in this study. We found that 
whilst 16S rRNA and rpoB gene sequencing could not differentiate A. pittii or A. calcoaceticus, 
they can be differentiated using gyrB multiplex PCR and MALDI – TOF MS. All ten 
Acinetobacter species investigated could be differentiated by their MALDI – TOF mass spectra.  
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1. Introduction 
Acinetobacter baumannii is an opportunistic, aerobic, Gram-negative nosocomial pathogen that 
has become one of the six most important multi-drug resistant microorganisms worldwide 
(Antunes et al., 2014). A. baumannii is commonly known to cause difficult to treat pneumonia, 
bacteremia, urinary tract infection, wound infection and meningitis (Maragakis and Perl, 2008).  
Accurate identification of A. baumannii and its closely related species A. pittii, A. nosocomialis 
and A. calcoaceticus is important as each of these species may display different characteristics in 
regards to antimicrobial susceptibilities, pathogenicity and clinical outcomes (Chuang et al., 
2011; Sedo et al., 2013). The environmental strain A. calcoaceticus has not been reported to 
cause infection in humans whilst the other organisms are all of clinical significance (Peleg et al., 
2008; Peleg et al., 2012). A recent paper has described increased severity and mortality in 
bacteraemia patients infected with A. baumannii compared with those infected with A. pitii and 
A. nosocomialis, emphasising the need for accurate differentiation (Fitzpatrick et al., 2015).  
However, these four species which together make up the A. calcoaceticus – A. baumannii (Acb) 
complex are indistinguishable by phenotypic based tests (Peleg et al., 2008; Wang et al., 2013; 
Lee et al., 2014).  
Molecular methods such as 16S rRNA and rpoB gene sequencing and have shown to be useful in 
differentiating members of the Acinetobacter genus (La Scola et al., 2006; Zarrilli et al., 2009; 
Wang et al., 2014). However, neither method is sufficient   to differentiate species such as A. 
pittii and A. calcoaceticus (Higgins et al., 2010), and other molecular methods such as PCR 
amplification of intrinsic resistance genes or gyrB are used. However, these methods are mainly 
applied in research settings and have very limited use in clinical laboratories (La Scola et al., 
2006; Higgins et al., 2010; Kamolvit et al., 2014). 
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Matrix assisted laser desorption ionisation – time of flight mass spectrometry (MALDI – TOF 
MS) has been shown to be a rapid and highly discriminatory method for the identification of 
bacteria (Kliem, 2010; Welker et al., 2011; Sedo et al., 2013). MALDI – TOF instruments that 
are commonly used in clinical settings for bacterial identification rely on the use of proprietary 
identification software and spectral databases (Martiny et al., 2012).  
In this study, we evaluated the use of a research-use-only (RUO) 5800 MALDI – TOF MS (AB 
SCIEX, Concord, ON, Canada) to differentiate and identify various species in the Acb complex, 
as well as other Acinetobacter spp. using only the standard instrument software and freely 
available open-source software for the acquisition, processing and interpretation of spectra. 
2. Materials and Methods 
2. 1. Bacterial isolates and reference strains 
The strains investigated in our study included thirty two multilocus sequence typed (MLST 
typed) A. baumannii isolates, six Acinetobacter reference strains and thirty five additional 
Acinetobacter isolates as described below: 
The MLST typed A. baumanni isolates included sixteen isolates of sequence type (ST)110, four 
isolates of ST92 and three isolates of ST109 (Huber et al., 2014). In addition to this, four isolates 
of from the Arabian peninsula were added to the study, including one isolate from Saudi Arabia 
of the ST195 and one of ST436, respectively, plus one isolate of ST208 from Kuwait and one of 
ST229 from Qatar (Zowawi et al., 2015).  
Two additional isolates of ST208 were of Japanese origin, and one isolate of ST208 was from 
Thailand, and two Singaporian strains were of ST491 (Kamolvit et al., unpublished data). The 
isolates from Japan, Thailand and Singapore were collected between 2008 and 2010, and the 
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MLST typing was performed in silico. The Kenyan strains and the strains from the Arabian 
peninsula were collected and MLST typed as previously described (Huber et al., 2014; Zowawi 
et al., 2015). MLST typing has been performed according to the Oxford scheme for all isolates 
(http://pubmlst.org/abaumannii/). 
 
The following reference strains and previously published isolates and were added to the study;     
A. baumannii ATCC 19606, A. calcoaceticus  ATCC 14987, A. lwoffi ATCC 15309 and ATCC 
17986, A. johnsonii ATCC 17909, A. junii ATCC 17908, A. baylyi (n=1), A. calcoaceticus (n=1), 
A. pitii (n=1) (Peleg et al., 2012) and A. nosocomialis (n=2) (Peleg et al., 2012; Carruthers et al., 
2013).  
Various additional Acinetobacter spp. from Kenya (n=4, provided by the AGA KHAN 
University hospital in Nairobi, Kenya and collected between 2010-2011), Japan (n=12, provided 
by the Toho University in Tokyo, Japan and collected in 2010 ), Australia (n=2, collected at the 
Royal Brisbane and Women’s hospital in Brisbane, Australia in 2004 and 2006 respectively), 
Thailand (n=7, provided by the Siriaj Hospital in Bangkok), Singapore (n=5, collected in 2008 
and provided by the National University of Singapore). All isolates were grown on Mueller 
Hinton agar and incubated for 24 hours in a 37
o
C incubator, and identification and confirmation 
of species was performed as described in chapter 2. 2. 
 
2. 2. 16S rRNA identification 
All Acinetobacter spp. isolates were initially identified by the sequencing of the 16S rRNA gene 
as previously described (Misbah et al., 2005). Sequencing was performed by Macrogen Inc, 
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Seoul, Korea, and sequences were blasted on NCBI using the megablast function against the 16S 
ribosomal RNA sequences database with maximum target sequences being set at 100. If 16S 
rRNA sequencing was unable to identify an isolate using the highest percentage identity, score 
and an E-value of 0 resulting in a  sequence that matches two species with identical lengths, rpoB 
gene sequencing of zone 1 and 2 was performed as previously described (La Scola et al., 2006). 
A previously described gyrB multiplex PCR (Higgins et al., 2010) was used to differentiate A. 
calcoaceticus and A. pittii. 
 
2. 3. MALDI - TOF MS 
MALDI – TOF MS analyses were conducted on a 5800 TOF/TOF set in linear positive mode 
running the TOF/TOF Series Explorer acquisition software (AB SCIEX, Framingham, 
Massachusetts) at a laser frequency of 100 Hz with a set mass range of 3,000 to 20,000 Da. A 
continuous stage motion set in a random pattern at 600 μm/sec was used for sampling. 
An in-house sinapinic acid matrix consisting of 10mg of sinapinic acid (>99.0% for MALDI-
MS, Fluka 85429) in 500 µL acetonitrile, 475 µL distilled water and 25 µL 80% trifluoroacetic 
acid (TFA, LC-MS grade, Fluka 40967) was adapted from a previously published protocol 
(Freiwald and Sauer, 2009). Calibration was performed using calibration mixture 2 (AB SCIEX, 
Framingham, Massachusetts) which contained Angiotensin I, ACTH (1-17 clip), ACTH (18-39 
clip), ACTH (7-38 clip) and insulin (bovine) to ensure mass accuracy within 5 ppm. 
2. 4. Acquisition of mass spectra  
A small amount of bacteria (approximately 10
6
 – 108 cfu) was transferred from a 24 hour culture 
by spreading a thin layer onto a sample spot on an Opti-TOF 384 MALDI plate insert (AB 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
SCIEX, Framingham, Massachusetts) and overlaid with 1 µL of sinapinic acid matrix. Each 
isolate was spotted in quadruplicate and each replicate scanned once. Laser intensity was set at 
4322 units and at a pulse rate of 100 Hz with a total of 1000 spectra accumulated for each 
sample. A mass range of m/z 3,000 to m/z 20,000 and a continuous stage motion set in a random 
pattern at 600 µm/sec was used for sampling. The TOF/TOF Series Explorer acquisition software 
(AB SCIEX, Framingham, Massachusetts) was used to acquire mass spectra. 
2. 5. Processing of spectra 
Mass spectra files were non-manipulatively converted from t2d files to mzXML files using a t2d 
converter (http://www.pepchem.org) and processed using mMass version 5.50 (Strohalm et al., 
2008) (http://www.mmass.org/). Processing of raw spectra was conducted in mMass 5.5 (Martin 
Strolham) with a peak picking algorithm that used baseline correction, Savitzky-Golay 
smoothing and a signal to noise ratio of 3. Replicates of the same isolates were averaged to form 
a consensus spectrum.  
 
3. Results 
3. 1. Bacterial identification  
Using 16S rRNA identification, we confirmed the following Acinetobacter spp. in our collection; 
A. baumannii (n=37), A. nosocomialis (n=15), Acinetobacter junii (n=3), Acinetobacter lwoffii 
(n=2), Acinetobacter johnsonii (n=1), Acinetobacter baylyi (n=1), Acinetobacter soli (n=1) and 
Acinetobacter bereziniae (n=1).  
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Using rpoB gene sequencing and gyrB multiplex PCR we determined the remaining fourteen 
strains to be A. pittii (n=12) and A. calcoaceticus (n=2). The results are as summarized in Table 
1. 
3. 2. MALDI – TOF MS based characterisation 
All ten Acinetobacter species investigated in our study had sufficient differences in their mass 
spectra to be characterised and differentiated using MALDI – TOF MS. In all of the A. 
baumannii strains investigated (n = 35) we observed the presence of a characteristic, high 
intensity mass of m/z 5743.05, as well as two other specific masses of m/z 8583.00 and m/z 
8715.00 that could be used to distinguish A. baumannii from other Acinetobacter spp. (Figure 1). 
Additionally, all the species that were not part of the Acb complex could also be characterised 
and differentiated (Summarised in Table 1).  
Nine of the twelve A. pittii isolates studied had a representative high intensity mass of m/z 
5780.03 and two other specific masses of m/z 8620.00 and m/z 8822.00. In addition, three of the 
twelve isolates were also characterized by a mass at m/z 5743.05, with similar intensity to that of 
the one in A. baumannii. However, the mass at m/z 5780.03 was absent (Figure 1).  
In A. nosocomialis we observed a representative mass at m/z 8134.00 in all isolates, and another 
mass at m/z 8542.00 in fourteen of fifteen isolates (Figure 2). In A. calcoaceticus, we observed a 
representative prominent peak at m/z 5829.00 that occurred in both isolates of this species 
(Figure 2). 
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4. Discussion 
Retrospective studies found that A. baumannii was associated with higher mortality rates, 
greater antimicrobial resistance and different clinical characteristics than the ones of A. 
nosocomialis and A. pittii (Chuang et al., 2011; Lee et al., 2011; Yang et al., 2013). This 
raises the importance of being able to differentiate the organisms within the Acb complex to 
allow for treatment to be optimised for specific organisms. 
A. calcoaceticus – A. baumannii complex organisms are hard to differentiate because of high 
phenotypic similarities (Gerner-Smidt et al., 1991). Molecular methods such as 16S rDNA 
and rpoB sequencing as well as gyrB PCR amplification are possible methods to discriminate 
between these strains. We observed that 16S rRNA sequencing or rpoB gene sequencing 
were not sufficient to differentiate A. pittii and A. calcoaceticus, and that the identification of 
these two organisms required gyrB multiplex PCR. However, in our investigation these 
species showed MALDI-TOF mass spectra that are clearly distinct from each other.  
MALDI is a soft desorption ionization method which may result in the formation of ions 
without significantly breaking chemical bonds, which is particularly useful in protein 
analysis. MALDI instruments commonly used for bacterial identification use licenced 
software packages that are incompatible with instruments of other brands. Such instruments 
are usually single TOF mass analysers that do not allow for efficient structure and sequence 
investigation of analytes. The ABSciex 5800 instrument in our laboratory is a TOF/TOF 
instrument which can overcome the limitations of a single TOF mass analyser by linking two 
TOF mass analysers in series, making it a much more powerful tool in protein research (Ng et 
al., 2014). However, due to the lack of a database, bacterial identification is not readily 
performed with this instrument. 
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The use of freeware to augment the abilities of RUO instruments such as the 5800 TOF/ TOF 
greatly increase the functionality and availability of these instruments for bacterial 
identification.  The ability to differentiate species without using automated systems may be a 
step back from the automated systems that the VITEK – MS and the Biotyper offer, but it 
validates the ability of MALDI – TOF instruments to visualise spectral differences for greater 
discrimination between closely related species.  
As we have seen in our study, MALDI – TOF was able to differentiate closely related species 
such as A. pittii and A. calcoaceticus. It appears that MALDI – TOF may also differentiate 
various Acinetobacter spp. from each other, as well as organisms that fall within the Acb 
complex. Automated processes would be required if this method is to be used as part of a 
diagnostic procedure.  
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Figure 1: Spectra acquired from A. baumannii and A. pittii. 
 
Figure 1: (A) Mass range of m/z 3000 – 7000 of A. baumannii and A. pittii. The red arrow 
indicates the mass of m/z 5743.05 and the blue arrow indicates the mass of m/z 5780.03. 
Three A. pittii isolates have the mass of m/z 5743.05, normally indicative of A. baumannii. 
However, none of the A. pittii isolates have both masses. (B) Mass Range of m/z 7000 – 
15000 of A. baumannii and A. pittii. The red arrows indicate the masses of m/z 8583.00 and 
m/z 8715.00 that are representative of A. baumannii. The blue arrows indicate the masses of 
m/z 8620.00 and m/z 8822.00 which are representative of A. pittii. 
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Figure 2: Spectra acquired from A. nosocomialis and A. calcoaceticus. 
 
Figure 2: (A) Mass range of m/z 3000 – 7000 of A. nosocomialis and A. calcoaceticus. The 
red arrow indicates the mass of m/z 5829.00 which is indicative of A. nosocomialis. (B) Mass 
Range of m/z 7000 – 15000 of A. nosocomialis and A. calcoaceticus. The blue arrows 
indicate the masses m/z 8134.00, m/z 8542.00, m/z 8315.00 or m/z 8356.00 or m/z 8481.00 
that are indicative of A. nosocomialis. 
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Table 1: 
Bacterial Species  Methods of species confirmation  
Indicative MALDI peak 
masses (m/z) 
A. baumannii (n = 35) 16S rRNA gene sequencing 
5743.05, 8583.00 and 
8715.00  
A. nosocomialis (n = 
15) 
16S rRNA gene sequencing 
8134.00, 8542.00 and 
8315.00 or 8356.00  or 
8481.00  
A. pittii (n = 12) 
16S rRNA gene sequencing, rpoB 
gene sequencing and gyrB multiplex 
PCR 
5743.05 or 5780.03, 
8620.00, 8822.00  
A. junii (n = 3) 16S rRNA gene sequencing 10,849.00  
A. calcoaceticus (n = 2) 
16S rRNA gene sequencing, rpoB 
gene sequencing and gyrB multiplex 
PCR  
5829.00 
A. lwoffii (n = 2) 16S rRNA gene sequencing 
7613.00, 7662.00, 9101.00 
and 9219.00 
A. johnsonii (n = 1) 16S rRNA gene sequencing 4309.00 and 6720.00  
A. baylyi (n = 1) 16S rRNA gene sequencing 5669.00  
A. soli (n = 1) 16S rRNA gene sequencing 5519.00 
A. bereziniae (n = 1) 16S rRNA gene sequencing  8018.00 and 9247.00 
 
Table 1: Acinetobacter spp. investigated in this study with the methods that were used to 
identify each species and their indicative MALDI peak masses 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
Highlights 
 
 A. baumannii is hard to differentiate from closely related Acinetobacter species. 
 MALDI – TOF based identification usually relies on proprietary software. 
 Here we differentiated A. baumannii from closely related Acinetobacter species. 
 Differentiation was done using MALDI-TOF and freely available open-source software. 
